MRC1 and cancer: Di-mannose nanocarriers that bind the mannose receptor CD206 on M2 macrophages, used to deliver in vitro-transcribed mRNA encoding M1-polarizing transcription factors, were shown to reprogram TAMs and improve survival in different cancer models (ovarian, lung metastasis) including GBM (104).